Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

[Intralesional treatment of classical Kaposi sarcoma with interferon-alpha].

Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete

Aged, therapy, pathology, immunology, Skin Neoplasms, Sarcoma, Kaposi, Recombinant Proteins, drug effects, Leukocyte Count, administration & dosage, Interferon-alpha, Injections, Intralesional, Immune Tolerance, Humans, Female, CD4-Positive T-Lymphocytes, CD4-CD8 Ratio

Read this article at

ScienceOpenPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      A 71-year-old female patient with classic Kaposi sarcoma (sarcoma idiopathicum haemorrhagicum multiplex) of the lower legs and one hand was treated with intralesional recombinant interferon alpha 2b. After 6 consecutive weeks of intratumoral injection of 1-3 million IU interferon-alpha 2b (Intron A) in three marked lesions, complete remission of intralesionally treated and of untreated tumours was observed. Even 9 months after treatment, the patient is still in complete remission. We conclude that this low dose and well-tolerated treatment schedule with interferon-alpha 2b is effective and a good alternative to radiation or chemotherapy in Kaposi sarcoma.

      Related collections

      Author and article information

      Journal
      1361927

      Comments

      Comment on this article